Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 984 entries
View as:

Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"

Phase: N/A Priority: Normal
NCT ID: NCT02139592 Org: User:
Start: 04/17/14 End: 06/30/17 Due: 06/30/18

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04074330 Org: User:
Start: 10/15/19 End: 04/26/23 Due: 04/26/24

Expanded Access to TAK-881 for Children and Teenagers With Primary Immunodeficiency Diseases in the USA

Phase: N/A Priority: Normal
NCT ID: NCT06955793 Org: User:
Start: - End: - Due: -

A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03215030 Org: User:
Start: 10/04/17 End: 11/07/24 Due: 11/07/25

A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05556616 Org: User:
Start: 10/27/22 End: 06/04/24 Due: 06/04/25

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05755035 Org: User:
Start: 10/24/23 End: 09/30/26 Due: 09/30/27

A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02451150 Org: User:
Start: 08/31/15 End: 09/30/15 Due: 09/30/16

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05918822 Org: User:
Start: 07/25/23 End: 09/01/23 Due: 09/01/24

A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

Phase: N/A Priority: Normal
NCT ID: NCT03488030 Org: User:
Start: 12/12/18 End: 05/31/19 Due: 05/31/20

Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00255151 Org: User:
Start: 01/31/06 End: 11/30/06 Due: 11/30/07

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Phase: N/A Priority: Normal
NCT ID: NCT03090139 Org: User:
Start: 03/28/17 End: 06/13/18 Due: 06/13/19

Virtual Celiac Symptoms Study in Adults and Teenagers

Phase: N/A Priority: Normal
NCT ID: NCT05309330 Org: User:
Start: 08/16/22 End: 03/04/23 Due: 03/04/24

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Phase: N/A Priority: Normal
NCT ID: NCT00449553 Org: User:
Start: 06/30/01 End: 09/30/03 Due: 09/30/04

Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00731120 Org: User:
Start: 06/30/08 End: 02/28/09 Due: 02/28/10

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05814016 Org: User:
Start: 05/11/23 End: 09/25/24 Due: 09/25/25

A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

Phase: N/A Priority: Normal
NCT ID: NCT06422377 Org: User:
Start: 04/25/24 End: 08/14/24 Due: 08/14/25

Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT01045096 Org: User:
Start: 03/31/10 End: 02/28/11 Due: 02/28/12

A Study of Real-World Outcomes of People With Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT05056441 Org: User:
Start: 12/01/21 End: 09/30/22 Due: 09/30/23

Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)

Phase: N/A Priority: Normal
NCT ID: NCT00074906 Org: User:
Start: 11/30/03 End: 06/30/08 Due: 06/30/09

TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02430870 Org: User:
Start: 04/30/15 End: 11/30/15 Due: 11/30/16

Magnetic Resonance Imaging in Subjects With Gouty Tophi

Phase: N/A Priority: Normal
NCT ID: NCT00174954 Org: User:
Start: 03/31/02 End: 01/31/03 Due: 01/31/04

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase: N/A Priority: Normal
NCT ID: NCT00117884 Org: User:
Start: 04/30/06 End: 06/30/08 Due: 06/30/09

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04844073 Org: User:
Start: 03/08/21 End: 11/01/26 Due: 11/01/27

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

Phase: N/A Priority: Normal
NCT ID: NCT04876365 Org: User:
Start: 11/30/21 End: 02/28/22 Due: 02/28/23

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Phase: N/A Priority: Normal
NCT ID: NCT04213209 Org: User:
Start: 02/14/20 End: 12/13/23 Due: 12/13/24